title: Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle.
authors.affiliation: I.C.R.F., Medical Oncology Unit, Western General Hospital, Edinburgh, UK.
authors.forename: P
authors.initials: P
authors.lastname: Mullen
authors.forename: W N
authors.initials: WN
authors.lastname: Scott
authors.forename: W R
authors.initials: WR
authors.lastname: Miller
mesh_terms: D001943:Breast Neoplasms; D002064:Buserelin / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects*; D002460:Cell Line; D002999:Clone Cells; D005260:Female; D016193:G1 Phase / Q000187:drug effects*; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D007700:Kinetics; D016192:Resting Phase, Cell Cycle / Q000187:drug effects*
chemical_list: D007987:Gonadotropin-Releasing Hormone; D002064:Buserelin